Breaking News
- Sermo Survey Reveals New Lung & Breast Cancer Research Rated as Most Interesting by Oncologists Attending ASCO This Year
- Eaton Introduces DC-DC Converters for 48-Volt Commercial Vehicle Architectures
- AGIC Capital Acquires a Majority Stake in Grafotronic
- Guidewire Elysian Release Accelerates Insurers’ Speed to Market with Integration Gateway, Guidewire GO, and Embedded Travel Insurance Solution
- FEELM Commits to Net-zero Carbon Emissions By 2050
- Labour and Social Development Minister opens Forum
- Cirium Partners With 3Victors to Offer the Most Dynamic Travel Demand Forecasting
- SD Specification 9 – New Opportunities for SD Memory Cards as Semi-Embedded Memory
- Metanomic Acquires Intoolab, Developers of the First Bayesian Network Artificial Intelligence Engine
- NBB launches “Points by NBB”
Booster shots approved for adolescents aged 12 to 17

Following approval by the Government Executive Committee, and based on the latest international data and developments, the National Medical Taskforce for Combatting the Coronavirus (COVID-19), has announced that the booster shot has been made available by choice for adolescents aged 12 to 17 years, starting Wednesday, 12 January 2022.
Adolescents in this age group who have received two doses of the Sinopharm vaccine will be offered the Sinopharm or Pfizer-BioNTech booster shots, approved for use from six months after the second dose. However, adolescents who have received both doses of the Pfizer-BioNTech vaccine will be offered the Pfizer-BioNTech booster shot only, also six months after the second dose.
The Taskforce also noted that the green shield will not change to yellow on the ‘BeAware’ application for this age group if they do not receive a booster shot.
The Taskforce noted that updating vaccination protocols are in line with steps taken by the Kingdom of Bahrain to address the global pandemic, and maintain public health.
bizbahrain